Abstract
Research on dopamine (DA) and its receptors, and in particular the D2 receptor subclass, has been an intriguing and fast developing scientific field in the past 35 years. Methods of medicinal chemistry, molecular and structural biology as well as computational chemistry were used in the studies of DA receptors (DRs). Early attempts to describe DRs were based on a small amount of experimental data available and produced crude models at best. Once crystal structures of bacteriorhodopsin, rhodopsine, various G-protein coupled receptors, and finally D3 DR receptor became available, better and more detailed D2 DR receptor models emerged. These models gave us an insight into the mechanism of ligand-receptor interactions, and paved the way for the synthesis of new dopaminergic compounds, both agonists and antagonists and possible drugs for the treatment of different imbalances of the dopaminergic system. This review covers the key discoveries on the path to the creation of the D2 DR receptor model.
Keywords: 3D structure, computational chemistry, dopamine, GPCR, homology modeling, receptor.
Current Medicinal Chemistry
Title:Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution
Volume: 22 Issue: 25
Author(s): Vladimir Sukalovic, Vukic Soskic and Sladjana Kostic-Rajacic
Affiliation:
Keywords: 3D structure, computational chemistry, dopamine, GPCR, homology modeling, receptor.
Abstract: Research on dopamine (DA) and its receptors, and in particular the D2 receptor subclass, has been an intriguing and fast developing scientific field in the past 35 years. Methods of medicinal chemistry, molecular and structural biology as well as computational chemistry were used in the studies of DA receptors (DRs). Early attempts to describe DRs were based on a small amount of experimental data available and produced crude models at best. Once crystal structures of bacteriorhodopsin, rhodopsine, various G-protein coupled receptors, and finally D3 DR receptor became available, better and more detailed D2 DR receptor models emerged. These models gave us an insight into the mechanism of ligand-receptor interactions, and paved the way for the synthesis of new dopaminergic compounds, both agonists and antagonists and possible drugs for the treatment of different imbalances of the dopaminergic system. This review covers the key discoveries on the path to the creation of the D2 DR receptor model.
Export Options
About this article
Cite this article as:
Sukalovic Vladimir, Soskic Vukic and Kostic-Rajacic Sladjana, Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution, Current Medicinal Chemistry 2015; 22 (25) . https://dx.doi.org/10.2174/0929867322666150716114316
DOI https://dx.doi.org/10.2174/0929867322666150716114316 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage
Current Alzheimer Research Bibliometrics of CNS & Neurological Disorders – Drug Targets: An International Evolution Along Time
CNS & Neurological Disorders - Drug Targets Foreword
Recent Patents on CNS Drug Discovery (Discontinued) Therapies for Hepatitis C Infection: Targeting the Non-Structural Proteins of HCV
Current Medicinal Chemistry - Anti-Infective Agents Analysis Of Sexual Behavior In Adolescents
Current HIV Research Cardiac Mitochondrial Alterations Observed in Hyperglycaemic Rats - What Can We Learn From Cell Biology?
Current Diabetes Reviews Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Current Topics in Medicinal Chemistry Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing- Remitting Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Pharmacological Treatment of Hypertension in Pregnancy
Current Pharmaceutical Design Congenital Cytomegalovirus Prevention, Awareness and Policy Recommendations - A Scoping Study
Infectious Disorders - Drug Targets Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Current Cancer Drug Targets Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review
Combinatorial Chemistry & High Throughput Screening Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins
Current Medicinal Chemistry Skin Cancers in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Ligand-Gated Pentameric ion Channels, from Binding to Gating
Current Molecular Pharmacology Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry Computational Analysis of TRAPPC9: Candidate Gene for Autosomal Recessive Non-Syndromic Mental Retardation
CNS & Neurological Disorders - Drug Targets MicroRNAs and Cancer; an Overview
Current Pharmaceutical Biotechnology Targeting Alpha-Synuclein for the Treatment of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets